Search for: "Merrel v. Research & Data, Inc." Results 1 - 20 of 75
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Dec 2018, 2:22 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), appealed a Ninth Circuit ruling that the Frye rule survived, and was incorporated into, the enactment of a statutory evidentiary rule, Rule 702. [read post]
28 May 2015, 2:29 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
10 Jun 2012, 1:09 pm by Schachtman
Sophisticated students of empirical research see the varied weaknesses, want to see the varied data, and draw more nuanced conclusions. [read post]
27 Jul 2017, 2:00 am
MERRELL DOW PHARMACEUTICALS, INC 509 U.S. 579 (1993)KOKKONEN V. [read post]
17 Jun 2022, 2:09 pm by admin
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
28 Feb 2024, 2:00 pm
Merrell Dow Pharms., Inc. (1993) 509 U.S. 579, 593 (Daubert); see also Primiano v. [read post]
17 Nov 2018, 12:10 pm by Schachtman
The Rothman brief does make the salutary point that labeling a study outcome as not “statistically significant” carries the danger that the study’s data have no value, or that the study may be taken to reject the hypothesized association. [read post]
30 Jan 2011, 5:29 pm by Scott Koller
Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.1995) (“ Daubert II ”). [read post]
23 Dec 2023, 7:16 pm by admin
“Know then thyself, presume not God to scan; The proper study of Mankind is Man. [read post]
3 May 2014, 8:56 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]